Bone Grafts and Substitutes Market Insights on Trends and Growth Forecast by 2032

Posted by Ganesh Shinde on January 13th, 2023

According to a recent market survey conducted by Future Market Insights (FMI), the global bone grafts and substitutes market was valued at .9 billion in 2021 and is expected to reach .3 billion by 2032. According to the report's findings, the spinal fusion segment by deployment mode will continue to be critical for the market, as it will generate the majority of revenue. According to the deployment model, the spinal fusion segment will account for a CAGR of 6.9% in 2032. The increasing number of SCI cases worldwide, which is a major factor in the high demand for bone grafts and substitutes in the spinal fusion segment.

The US to Command the Larger Proportion of Bone Grafts and Substitutes Market throughout the Analysis Period

The United States controls 37.3% of the market and is expected to maintain its position with an absolute opportunity growth of US$ 1.2 billion to reach a valuation of US$ 2.4 billion by 2032. Its demand in the United States is expected to rise due to the rapidly increasing demand for bone grafts and substitutes in Spinal Cord Injuries (SCIs). According to the CDC, 67 million adults in the United States will have arthritis by 2030, increasing the demand for bone grafts, which are required for arthritis treatment.

“The use of allograft bone grafts in demineralized bone matrices procedures has the potential to emerge as a key market driver for the Bone Grafts and Substitutes market during the forecast period.” comments an analyst at Future Market Insights.

Bone Grafts and Substitutes Market: Competition Insights

Currently, providers of Bone Grafts and Substitutes are focusing on strategies such as mergers, acquisitions, and partnerships. They're attempting to strike a balance between expanding their product portfolio and capitalising on rising market demand. Allosource, DePuySynthes Inc., Baxter, NuVasive Inc., Smith & Nephew, Medtronic, Orthofix Holdings Inc., TBF Tissue Engineering, Stryker Corporation, OrthoFix Medical Inc., MedBone Biomaterials, and SeaSpine are among the key players in the Bone Grafts and Substitutes market.

Read More Details@ https://www.futuremarketinsights.com/reports/bone-grafts-and-substitutes-market

The key recent developments of Bone Grafts and Substitutes manufacturers are as follows:

• Orthofix Medical Inc. launched Opus B.A., a highly efficient and synthetic bioactive bone graft solution, in February 2022 to aid in the process of cervical and lumbar spine fusions.
• NuVasive Inc. acquired Simplify Medical in February 2021 to strengthen the company's cervical portfolio, thereby expanding its growth avenues during the forecast period.
• Stryker Corporation completed its acquisition of Wright Medical Group N.V. in November 2020. The acquisition of this medical equipment company specialising in extremities and biologics is expected to help Stryker Corporation improve its bone graft substitute portfolio and expand its market position.

• In July 2020, Baxter's Altapore Shape bioactive bone graft has been approved by the FDA. Among the many benefits of this bone graft are increased bone growth.